SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001388410-16-000041
Filing Date
2016-09-26
Accepted
2016-09-23 18:21:21
Documents
9
Period of Report
2016-09-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f20160922prlx8k.htm 8-K 25259
2 EX 2.4 PURCHASE AND SALE AGREEMENT ex24.htm EX-2 856496
3 EX 10.33 ASSIGNMET AGREEMENT ex1033.htm EX-10 1067
4 EX 10.34 LICENSE ROYALTY AGREEMENT ex1034.htm EX-10 418779
5 IMAGE ex1033002.gif GRAPHIC 4357581
6 IMAGE ex1033004.gif GRAPHIC 4357581
7 IMAGE ex1033006.gif GRAPHIC 4336221
8 IMAGE ex1033008.gif GRAPHIC 4336221
9 IMAGE f20160922prlx8k001.jpg GRAPHIC 15743
  Complete submission text file 0001388410-16-000041.txt   24087002
Mailing Address 1327 OCEAN AVENUE, SUITE M SANTA MONICA CA 90401
Business Address 1327 OCEAN AVENUE, SUITE M SANTA MONICA CA 90401 310-899-4442
PARALLAX HEALTH SCIENCES, INC. (Filer) CIK: 0001388410 (see all company filings)

IRS No.: 721619357 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52534 | Film No.: 161900703
SIC: 5912 Retail-Drug Stores and Proprietary Stores